Skip to main content

Table 1 General features of patients with dermatomyositis and antisynthetase syndrome at disease onset

From: The aerobic capacity in patients with antisynthetase syndrome and dermatomyositis

 

DM

(n = 13)

ASS

(n = 9)

P

Age at disease diagnosis (years)

40.2 ± 11.5

40.2 ± 10.2

0.999

Clinical manifestations (%)

 Constitutional symptoms

8 (61.5)

8 (88.9)

0.333

Skin involvement

 Heliotrope rash

12 (92.3)

0

 Gottron’s sign

12 (92.3)

0

 Gottron’s papule

12 (92.3)

0

  “Mechanic’s hands”

0

6 (66.7)

 Joint involvement

2 (15.4)

8 (88.9)

0.001

 Pulmonary involvement

4 (30.8)

9 (100.0)

0.001

 Raynaud’s phenomenon

6 (46.2)

8 (88.9)

0.165

 Dysphagia

8 (61.5)

3 (33.3)

0.193

Muscle involvement (%)

Upper limbs (muscle strength)

 Degree II

0

0

0.689

 Degree II

0

0

 Degree III

2 (15.8)

2 (22.2)

 Degree IV

11 (84.2)

6 (66.7)

 Degree V

0

1 (11.1)

Lower limbs (muscle strength)

 Degree II

0

0

0.973

 Degree II

0

0

 Degree III

3 (23.1)

2 (22.2)

 Degree IV

9 (69.2)

6 (66.7)

 Degree V

1 (7.7)

1 (11.1)

Laboratory parameters

 Creatine phosphokinase (U/L)

2300 (999–6326)

967 (292–6654)

0.366

Antisynthetase autoantibodies (%)

 Anti- Jo-1

0

8 (88.9)

 Anti-PL-12

0

1 (11.1)

  1. ASS antisynthetase syndrome, DM dermatomyositis